Breaking News

You are here » Indian-Commodity  :  Top News  :  Cipla in partnership with MMV launches quality-assured RAS

26-Jul2017

Cipla in partnership with MMV launches quality-assured RAS

Cipla, a global pharmaceutical company, and the product development partnership Medicines for Malaria Venture (MMV) has launched 100 mg Artesunate Rectocaps/Rectal Artesunate Suppositories (RAS), a life-saving, pre-referral intervention for the management of severe malaria in young children.

Cipla's RAS product contains 100 mg of Artesunate and is indicated in children from 6 months to 6 years. It was developed with the support of MMV (with UNITAID financing) and will now soon be available in four sub-Saharan countries.

Initially developed by the World Health Organization's (WHO) Tropical Diseases Research programme, RAS 100 mg manufactured by Cipla was recently added to the Global Fund Expert Review Panel's list of quality-assured medicines, while the process of WHO prequalification of this medicine moves through its final stages. This authorization makes it the first quality-assured RAS product.

Cipla is a global pharmaceutical company which uses cutting edge technology and innovation to meet the everyday needs of all patients. For 80 years, Cipla has emerged as one of the most respected pharmaceutical names in India as well as across more than 100 countries.




Related News

View all news

Barley futures trade in green on firm demand

Barley futures traded higher on NCDEX, with the frantic buying by stockists and retailers on the back of firm demand from consuming industries. Moreover, pause in arrivals from growing regions also fuelled......

Nickel futures edge higher on pickup in demand

Nickel futures edged higher on MCX as participants built up fresh positions on the back of pickup in demand from alloy-makers and other consuming industries at the spot market. Besides, a firming trend......

Turmeric futures trade higher on pick up in demand

Turmeric futures traded higher on NCDEX, as speculators engaged in fresh buying after previous session lower prices on back of pick up in spot demand. Even though, reports of improved sowing turmeric growing......

Top News

View all news

Sun Pharma receives Australian TGA approval for ILUMYA

Sun Pharmaceutical Industries has received the Australian Therapeutic Goods Administration (TGA) approval for its specialty product, ILUMYA (tildrakizumab) for the treatment of adults with moderate-to-severe......

TCS features as leader in Everest Group PEAK Matrix for F&A Digital Augmentation Suite

Tata Consultancy Services (TCS) has been positioned as a leader in the Everest Group PEAK Matrix for Finance and Accounting (F&A) Digital Augmentation Suite (DAS).Cited as a strength is the company's......

Infosys enters into exclusive partnership with Trinity College

Infosys has entered into an exclusive partnership with Trinity College to create new educational programs that prepare liberal arts students and Infosys employees for the digital workplace of the future.......